Search
Search Results
-
Acute graft-versus-host disease
Acute graft-versus-host disease (GVHD) is a common immune complication that can occur after allogeneic haematopoietic cell transplantation (alloHCT)....
-
Understanding and treatment of cutaneous graft-versus-host-disease
The skin is the outermost mechanical barrier where dynamic immune reactions take place and is the most commonly affected site in both acute and...
-
The diagnostic conundrum of acute cutaneous graft-versus-host disease: biomarkers remain elusive
Hematopoietic stem cell transplantation is increasing in frequency with graft-versus-host disease affecting many recipients. When the skin is...
-
Acute Graft-versus-Host Disease: An Update on New Treatment Options
Acute graft-versus-host disease (GVHD) occurs in approximately 50% of patients and remains a primary driver of non-relapse and transplant-related...
-
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation
Graft-versus-host disease is among the most common clinical complications following allogeneic hematopoietic stem cell transplantation. It causes...
-
Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program
The ruxolitinib compassionate use (CU) program offered ruxolitinib to patients ≥2 years of age with confirmed steroid-resistant acute or chronic...
-
-
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
Acute graft-versus-host disease (aGVHD) remains a major limitation of allogeneic hematopoietic stem cell transplantation; not all patients respond to...
-
Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease
Acute graft versus host disease (aGVHD) is a complication of allogeneic hematopoietic stem cell transplant (HCT) and is associated with significant...
-
Potential of TCR sequencing in graft-versus-host disease
Graft-versus-host disease (GvHD) remains one of the major complications following allogeneic haematopoietic stem cell transplantation (allo-HSCT)....
-
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis
Steroid-refractory acute graft-versus-host disease (aGvHD) is a serious complication after allogeneic hematopoietic stem cell transplantation,...
-
The effect of danger-associated molecular patterns on survival in acute graft versus host disease
Danger-associated molecular patterns (DAMPs) are molecules that can initiate and maintain robust inflammatory responses and were investigated in the...
-
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation
Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the only curative treatment for myelofibrosis (MF). Relapse occurs in 10–30%...
-
PET assessment of acute gastrointestinal graft versus host disease
Acute gastrointestinal graft versus host disease (GI-GVHD) is a common complication following allogeneic haematopoietic cell transplantation (HCT),...
-
Isolated massive pleural effusion as a manifestation of chronic graft versus host disease successfully treated with corticosteroid
Isolated pleural effusion is a rare manifestation of chronic graft versus host disease (cGVHD) after hematopoietic stem cell transplantation (HSCT)....
-
Treatment of oral graft-versus-host disease with intraoral nbUVB phototherapy
PurposeThere are limited treatment options available for hematopoietic stem-cell transplant patients (HSCT) with oral graft-versus-host disease...
-
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation
The reduced risk of chronic graft-versus-host-disease (GVHD) with posttransplant cyclophosphamide (ptCy) in the setting of haploidentical related...
-
Advances in graft-versus-host disease prevention strategies: latest updates from the 2022 ASH annual meeting
This review summarizes the significant advancements in prophylaxis against graft-versus-host disease (GvHD) presented at the 2022 ASH Annual Meeting....
-
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease
Kidney complications have been studied in allogeneic hematopoietic stem cell transplant patients but not specifically among chronic graft-versus-host...
-
